Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 2 | Alzheimer's Research & Therapy

Fig. 2

From: Prescreening for European Prevention of Alzheimer Dementia (EPAD) trial-ready cohort: impact of AD risk factors and recruitment settings

Fig. 2

Multivariate model for enrolment and amyloid positivity. Legend: EPAD-LCS = EPAD longitudinal cohort study (trial-ready cohort). APOE = apolipoprotein E gene. Shown effect sizes are: Age per 5 years older at baseline, APOE ɛ4 in contrast to no APOE ɛ4, male in contrast to female, highly educated in contrast to low or normal level educated, family history for dementia positive in contrast to family history for dementia reported

Back to article page